Investor's Business Daily10d agoneutral
IPO Stock LB Pharma Has Tripled In Under A Year. Is It A Takeover Target?LB Pharmaceuticals is on a tear. The IPO stock has more than tripled as investors watch its efforts in neuropsychiatric disorders.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
72last 24h
975last 7d
109● bullish (7d)
124● bearish (7d)
212publishers
24/7 Wall St.30d agoneutral
Why Bristol Myers, Johnson & Johnson and More Are Watching Seaport After IPOSeaport Therapeutics just went public with a prodrug platform that has attracted board members from two of the biggest neuroscience acquisitions in recent history. The question is whether the same giants who funded those deals are already circling for a third.
PA Media: Money47d agoneutral
Stocks mixed as AstraZeneca merger talk dents FTSE 100The FTSE 100 index closed down 10.35 points, 0.1%, at 10,857.70.
MT Newswires50d agoneutral
AbbVie Trims Full-Year Profit Outlook Due to Apogee AcquisitionAbbVie (ABBV) lowered its full-year earnings guidance on Friday to account for the expected dilution
Quartz103d agoneutral
Johnson & Johnson acquires Firefly Bio for $1 billionThe deal targets KRAS-driven tumors, which J&J says have limited treatment options and survival measured in months